Autolus Therapeutics plc Subsidiaries
Every subsidiary the company listed in Exhibit 21 of its annual reports, newest list first (3 lists). Names and jurisdictions are as filed.
- 2026-03-27: Subsidiary Autolus Holdings (UK) Limited; Jurisdiction England and Wales.
- 2026-03-27: Subsidiary Autolus Limited; Jurisdiction England and Wales.
- 2026-03-27: Subsidiary Autolus Inc.; Jurisdiction Delaware.
- 2026-03-27: Subsidiary Autolus GmbH; Jurisdiction Germany.
| Annual report filed | Subsidiary | Jurisdiction |
|---|---|---|
| 2026-03-27 | Autolus Holdings (UK) Limited | England and Wales |
| 2026-03-27 | Autolus Limited | England and Wales |
| 2026-03-27 | Autolus Inc. | Delaware |
| 2026-03-27 | Autolus GmbH | Germany |
| 2026-03-27 | Autolus Switzerland AG | Switzerland |
| 2025-03-20 | Autolus Holdings (UK) Limited | England and Wales |
| 2025-03-20 | Autolus Limited | England and Wales |
| 2025-03-20 | Autolus Inc. | Delaware |
| 2025-03-20 | Autolus GmbH | Germany |
| 2025-03-20 | Autolus Switzerland AG | Switzerland |
| 2024-03-21 | Autolus Holdings (UK) Limited | England and Wales |
| 2024-03-21 | Autolus Limited | England and Wales |
| 2024-03-21 | Autolus Inc. | Delaware |
| 2024-03-21 | Autolus GmbH | Germany |
| 2024-03-21 | Autolus Switzerland AG | Switzerland |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 |